Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition

被引：54
|
作者：
Napolitano, M. [1 ]
Megna, M. [2 ]
Fabbrocini, G. [2 ]
Nistico, S. P. [3 ]
Balato, N. [2 ]
Dastoli, S. [3 ]
Patruno, C. [3 ]
机构：
[1] Univ Molise, Dept Med & Hlth Sci Vincenzo Tiberio, Campobasso, Italy
[2] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy
[3] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 181卷 / 03期
关键词：
DRUG ERUPTION; DISEASES;
D O I：
10.1111/bjd.17779
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：604 / 606
页数：3
相关论文
共 50 条
  • [31] Interleukin-17 Antagonists in the Treatment of Psoriasis
    Chandrakumar, Shivani Felicia
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2015, 19 (02) : 109 - 114
  • [32] To Be 17 Again - Anti-Interleukin-17 Treatment for Psoriasis (vol 366, pg 1251, 2012)
    Waisman, Ari
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (01): : 93 - 93
  • [33] Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents
    Roccuzzo, Gabriele
    Mastorino, Luca
    Susca, Sara
    Cariti, Caterina
    Passerini, Stefania G.
    Sciamarrelli, Nadia
    Borriello, Silvia
    Macagno, Nicole
    Sliquini, Niccolo
    Avallone, Gianluca
    Verrone, Anna
    Stroppiana, Elena
    Quaglino, Pietro
    Ortoncelli, Michela
    Dapavo, Paolo
    Ribero, Simone
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (04) : 379 - 381
  • [34] Osteolytic Lesion in PAPA Syndrome Responding to Anti-interleukin 1 Treatment
    Caorsi, Roberta
    Picco, Paolo
    Buoncompagni, Antonella
    Martini, Alberto
    Gattorno, Marco
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (11) : 2333 - 2334
  • [35] Is there room for another anti-interleukin-17 treatment in the crowded psoriasis therapeutic landscape?
    Bergqvist, Christina
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (06) : e76 - e77
  • [36] Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases
    Rezan Topaloglu
    Ezgi Deniz Batu
    Diclehan Orhan
    Seza Ozen
    Nesrin Besbas
    Pediatric Nephrology, 2016, 31 : 633 - 640
  • [37] Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents
    Talamonti, Marina
    Galluzzo, Marco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (11) : 1535 - 1537
  • [38] Another anti-interleukin (IL)-17 inhibitor: is there an advantage of blocking IL-17A and IL-17F?
    Gerdes, Sascha
    Albrecht, Joerg
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : 603 - 604
  • [39] Use of anti-interleukin 6 receptor monoclonal antibody for the treatment of Endometriosis
    Abou-EL-Naga, Amoura M.
    El-Zayadi, Ahmed A.
    Tag, Yasmin M.
    Fawzy, Nada M.
    BIOSCIENCE RESEARCH, 2022, 19 (02): : 836 - 843
  • [40] Results of a phase II study of a human anti-interleukin (IL)-12/IL-23 monoclonal antibody in the treatment of psoriasis
    Langley, R
    Lebwohl, M
    Leonardi, C
    Yeilding, N
    Guzzo, C
    Wang, Y
    Dooley, L
    Krueger, GG
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (01) : A6 - A6
12345